Dermalax Deep Plus (1×1.1ml)

The gel acts as a mechanical support, physically displacing the mid-to-deep dermis to smooth wrinkles and add volume. While skin boosters focus on surface hydration, Dermalax Deep Plus provides the "G-prime" needed to hold its shape against the pressure of facial expressions. For comprehensive rejuvenation, combining this filler with Jalupro HMW can enhance the final outcome by improving skin density and hydration.

The formulation contains 24 mg/ml of monophasic cross-linked Sodium Hyaluronate and 0.3% Lidocaine hydrochloride. This concentration is designed for long-term stability and high biocompatibility within the human tissue.

Dosage is individualized based on the patient's anatomy and the depth of the target wrinkles. For lip enhancement or nasolabial correction, 1.1 ml is typically sufficient for a standard session. Practitioners should evaluate if 0.5 ml of filler is appropriate for minor touch-ups before utilizing the full syringe capacity. It is often transitioned with Regenovue Deep Plus in clinical protocols focusing on volume restoration.

Common reactions include temporary redness, swelling, and localized purple bruising at the injection sites. These effects generally resolve within 3 to 7 days. To ensure professional safety standards, practitioners must have Liporase (Hyaluronidase) available on-site to manage any rare aesthetic irregularities or vascular concerns immediately.

Avoid alcohol for 24h before and 48h after the procedure. Alcohol consumption leads to vasodilation, which can exacerbate post-procedural edema and increase the visibility of bruising at the entry points, potentially extending the downtime.

Treatment is strictly contraindicated. No clinical safety data exists for the use of cross-linked HA fillers during pregnancy or the breastfeeding period. Practitioners must monitor for signs of vascular occlusion in all patients and defer elective procedures for those who are pregnant to prioritize maternal health.